Making AI Headlines · Page 8

Chemistry's Trial and Error Gets a Better Appointment Scheduler

November 7, 2026 at 6:01 AM EST · New York time

A machine-learning approach called CheMeleon aims to help researchers predict molecular behavior from limited data and guide the development of drugs and other molecules with less detailed, expensive experimentation, according to MIT News. Finding molecules with useful properties matters across pharmaceuticals, electronics and energy. It is also difficult: a compound can behave in many ways, and researchers cannot perfectly predict every property in advance. Experiments and calculations help narrow the possibilities, but both can require considerable work. CheMeleon is intended to give scientists a more practical way to guide that search when detailed data is scarce. If a model can help identify promising candidates, researchers may be able to make better choices about what to investigate. The approach is a guide to development, not evidence that experiments or scientific judgment have become unnecessary. The appeal is not that a computer can make chemistry effortless. It is that researchers might spend less time pursuing candidates that a useful prediction could have helped them set aside. That is a less dramatic promise than replacing the lab, but a potentially valuable one for the people paying for and conducting experiments. Science is full of ideas that looked excellent before being tested. CheMeleon offers to improve the guest list before those ideas arrive at the lab. The experiments still get the final word, which is reassuring for anyone who has ever met a very confident prediction.

Satire. Not factual reporting. Read the original reporting from the linked publishers.